MedPath
HSA Approval

LANOTAN OPHTHALMIC SOLUTION 0.005% w/w

SIN14399P

LANOTAN OPHTHALMIC SOLUTION 0.005% w/w

LANOTAN OPHTHALMIC SOLUTION 0.005% w/w

August 27, 2013

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED
Licence HolderBAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01EE01

latanoprost

Manufacturer Information

BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED

BAUSCH & LOMB INCORPORATED (TAMPA)

Active Ingredients

LATANOPROST

0.005% w/w

Latanoprost

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LANOTAN OPHTHALMIC SOLUTION 0.005% w/w - HSA Approval | MedPath